Notice2022-01027

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 20, 2022

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 13 (Thursday, January 20, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 13 (Thursday, January 20, 2022)]
[Notices]
[Page 3110]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01027]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Arthritis and Musculoskeletal and Skin 
Diseases Initial Review Group; Arthritis and Musculoskeletal and 
Skin Diseases Clinical Trials Study Section.
    Date: February 17-18, 2022.
    Time: 9:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Arthritis and Musculoskeletal and 
Skin Diseases, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Kathy Salaita, SCD, Chief, Scientific Review 
Branch, National Institute of Arthritis and Musculoskeletal and Skin 
Diseases, 6701 Democracy Boulevard, Suite 800, Bethesda, MD 20892, 
301-594-5033, <a href="/cdn-cgi/l/email-protection#aac1cbdec2d384d9cbc6cbc3decbeac4c3c284cdc5dc"><span class="__cf_email__" data-cfemail="9bf0faeff3e2b5e8faf7faf2effadbf5f2f3b5fcf4ed">[email&#160;protected]</span></a>.

    Name of Committee: Arthritis and Musculoskeletal and Skin 
Diseases Initial Review Group; Arthritis and Musculoskeletal and 
Skin Diseases Special Grants Study Section.
    Date: February 24-25, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Arthritis and Musculoskeletal and 
Skin Diseases, 6701 Democracy Blvd., Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Helen Lin, Ph.D., Scientific Review Officer, 
Scientific Review Branch, National Institute of Arthritis, 
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Suite 
800, Bethesda, MD 20892, 301-594-4952, <a href="/cdn-cgi/l/email-protection#1a767374722b5a777b737634747372347d756c"><span class="__cf_email__" data-cfemail="5a363334326b1a373b333674343332743d352c">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: January 13, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01027 Filed 1-19-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 20, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.